SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $14,358,000 | +0.9% | 192,650 | +130.9% | 0.07% | -13.6% |
| Q4 2020 | $14,223,000 | +86.4% | 83,424 | +47.6% | 0.08% | +19.1% |
| Q3 2020 | $7,630,000 | -20.7% | 56,538 | -8.8% | 0.07% | -46.0% |
| Q2 2020 | $9,626,000 | -55.0% | 62,001 | -71.6% | 0.13% | -37.3% |
| Q1 2020 | $21,390,000 | +36.0% | 218,670 | +79.5% | 0.20% | -19.0% |
| Q4 2019 | $15,724,000 | +67.5% | 121,855 | -2.2% | 0.25% | +48.5% |
| Q3 2019 | $9,387,000 | -29.4% | 124,623 | +42.4% | 0.17% | -36.0% |
| Q2 2019 | $13,294,000 | +156.8% | 87,492 | +101.5% | 0.26% | +90.5% |
| Q1 2019 | $5,177,000 | – | 43,431 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |